Clinical Trial Results

esperion

Esperion Announces Positive Phase 2 Clinical Trial Results for ETC-1002

Esperion Therapeutics, a privately held biotechnology company in Plymouth, Monday announced positive results from a Phase 2 clinical trial for its potential cholesterol buster, ETC-1002.

WWJ Newsradio 950–03/26/2012

Follow

Get every new post delivered to your Inbox.

Join 2,057 other followers